1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Intravenous Immunoglobulin (IVIg) Revenue
1.4 Market Analysis by Type
1.4.1 Global Intravenous Immunoglobulin (IVIg) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 IVIg Liquid
1.4.3 IVIg Powder
1.5 Market by Application
1.5.1 Global Intravenous Immunoglobulin (IVIg) Market Share by Application: 2021-2026
1.5.2 Immunodeficiency
1.5.3 Autoimmune Disease
1.5.4 Acute Infection
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Intravenous Immunoglobulin (IVIg) Market
1.8.1 Global Intravenous Immunoglobulin (IVIg) Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Intravenous Immunoglobulin (IVIg) Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Intravenous Immunoglobulin (IVIg) Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Intravenous Immunoglobulin (IVIg) Sales Volume Market Share by Region (2015-2020)
3.2 Global Intravenous Immunoglobulin (IVIg) Sales Revenue Market Share by Region (2015-2020)
3.3 North America Intravenous Immunoglobulin (IVIg) Sales Volume
3.3.1 North America Intravenous Immunoglobulin (IVIg) Sales Volume Growth Rate (2015-2020)
3.3.2 North America Intravenous Immunoglobulin (IVIg) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Intravenous Immunoglobulin (IVIg) Sales Volume
3.4.1 East Asia Intravenous Immunoglobulin (IVIg) Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Intravenous Immunoglobulin (IVIg) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Intravenous Immunoglobulin (IVIg) Sales Volume (2015-2020)
3.5.1 Europe Intravenous Immunoglobulin (IVIg) Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Intravenous Immunoglobulin (IVIg) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Intravenous Immunoglobulin (IVIg) Sales Volume (2015-2020)
3.6.1 South Asia Intravenous Immunoglobulin (IVIg) Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Intravenous Immunoglobulin (IVIg) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Volume (2015-2020)
3.7.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Intravenous Immunoglobulin (IVIg) Sales Volume (2015-2020)
3.8.1 Middle East Intravenous Immunoglobulin (IVIg) Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Intravenous Immunoglobulin (IVIg) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Intravenous Immunoglobulin (IVIg) Sales Volume (2015-2020)
3.9.1 Africa Intravenous Immunoglobulin (IVIg) Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Intravenous Immunoglobulin (IVIg) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Intravenous Immunoglobulin (IVIg) Sales Volume (2015-2020)
3.10.1 Oceania Intravenous Immunoglobulin (IVIg) Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Intravenous Immunoglobulin (IVIg) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Intravenous Immunoglobulin (IVIg) Sales Volume (2015-2020)
3.11.1 South America Intravenous Immunoglobulin (IVIg) Sales Volume Growth Rate (2015-2020)
3.11.2 South America Intravenous Immunoglobulin (IVIg) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Intravenous Immunoglobulin (IVIg) Sales Volume (2015-2020)
3.12.1 Rest of the World Intravenous Immunoglobulin (IVIg) Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Intravenous Immunoglobulin (IVIg) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Intravenous Immunoglobulin (IVIg) Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Intravenous Immunoglobulin (IVIg) Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Intravenous Immunoglobulin (IVIg) Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Intravenous Immunoglobulin (IVIg) Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Intravenous Immunoglobulin (IVIg) Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Intravenous Immunoglobulin (IVIg) Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Intravenous Immunoglobulin (IVIg) Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Intravenous Immunoglobulin (IVIg) Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Intravenous Immunoglobulin (IVIg) Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Intravenous Immunoglobulin (IVIg) Sales Volume Market Share by Type (2015-2020)
14.2 Global Intravenous Immunoglobulin (IVIg) Sales Revenue Market Share by Type (2015-2020)
14.3 Global Intravenous Immunoglobulin (IVIg) Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Intravenous Immunoglobulin (IVIg) Consumption Volume by Application (2015-2020)
15.2 Global Intravenous Immunoglobulin (IVIg) Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Intravenous Immunoglobulin (IVIg) Business
16.1 Baxter
16.1.1 Baxter Company Profile
16.1.2 Baxter Intravenous Immunoglobulin (IVIg) Product Specification
16.1.3 Baxter Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 CNBG
16.2.1 CNBG Company Profile
16.2.2 CNBG Intravenous Immunoglobulin (IVIg) Product Specification
16.2.3 CNBG Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Octapharma
16.3.1 Octapharma Company Profile
16.3.2 Octapharma Intravenous Immunoglobulin (IVIg) Product Specification
16.3.3 Octapharma Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Grifols
16.4.1 Grifols Company Profile
16.4.2 Grifols Intravenous Immunoglobulin (IVIg) Product Specification
16.4.3 Grifols Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Hualan Bio
16.5.1 Hualan Bio Company Profile
16.5.2 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Specification
16.5.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 CSL
16.6.1 CSL Company Profile
16.6.2 CSL Intravenous Immunoglobulin (IVIg) Product Specification
16.6.3 CSL Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 CBPO
16.7.1 CBPO Company Profile
16.7.2 CBPO Intravenous Immunoglobulin (IVIg) Product Specification
16.7.3 CBPO Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Kedrion
16.8.1 Kedrion Company Profile
16.8.2 Kedrion Intravenous Immunoglobulin (IVIg) Product Specification
16.8.3 Kedrion Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Biotest
16.9.1 Biotest Company Profile
16.9.2 Biotest Intravenous Immunoglobulin (IVIg) Product Specification
16.9.3 Biotest Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Shanghai RAAS
16.10.1 Shanghai RAAS Company Profile
16.10.2 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Specification
16.10.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 LFB Group
16.11.1 LFB Group Company Profile
16.11.2 LFB Group Intravenous Immunoglobulin (IVIg) Product Specification
16.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 BPL
16.12.1 BPL Company Profile
16.12.2 BPL Intravenous Immunoglobulin (IVIg) Product Specification
16.12.3 BPL Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Sichuan Yuanda Shuyang
16.13.1 Sichuan Yuanda Shuyang Company Profile
16.13.2 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Specification
16.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Intravenous Immunoglobulin (IVIg) Manufacturing Cost Analysis
17.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
17.4 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Intravenous Immunoglobulin (IVIg) Distributors List
18.3 Intravenous Immunoglobulin (IVIg) Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Intravenous Immunoglobulin (IVIg) (2021-2026)
20.2 Global Forecasted Revenue of Intravenous Immunoglobulin (IVIg) (2021-2026)
20.3 Global Forecasted Price of Intravenous Immunoglobulin (IVIg) (2015-2026)
20.4 Global Forecasted Production of Intravenous Immunoglobulin (IVIg) by Region (2021-2026)
20.4.1 North America Intravenous Immunoglobulin (IVIg) Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Intravenous Immunoglobulin (IVIg) Production, Revenue Forecast (2021-2026)
20.4.3 Europe Intravenous Immunoglobulin (IVIg) Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Intravenous Immunoglobulin (IVIg) Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Intravenous Immunoglobulin (IVIg) Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Intravenous Immunoglobulin (IVIg) Production, Revenue Forecast (2021-2026)
20.4.7 Africa Intravenous Immunoglobulin (IVIg) Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Intravenous Immunoglobulin (IVIg) Production, Revenue Forecast (2021-2026)
20.4.9 South America Intravenous Immunoglobulin (IVIg) Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Intravenous Immunoglobulin (IVIg) Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Intravenous Immunoglobulin (IVIg) by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Intravenous Immunoglobulin (IVIg) by Country
21.2 East Asia Market Forecasted Consumption of Intravenous Immunoglobulin (IVIg) by Country
21.3 Europe Market Forecasted Consumption of Intravenous Immunoglobulin (IVIg) by Countriy
21.4 South Asia Forecasted Consumption of Intravenous Immunoglobulin (IVIg) by Country
21.5 Southeast Asia Forecasted Consumption of Intravenous Immunoglobulin (IVIg) by Country
21.6 Middle East Forecasted Consumption of Intravenous Immunoglobulin (IVIg) by Country
21.7 Africa Forecasted Consumption of Intravenous Immunoglobulin (IVIg) by Country
21.8 Oceania Forecasted Consumption of Intravenous Immunoglobulin (IVIg) by Country
21.9 South America Forecasted Consumption of Intravenous Immunoglobulin (IVIg) by Country
21.10 Rest of the world Forecasted Consumption of Intravenous Immunoglobulin (IVIg) by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer